Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock
Top Cited Papers
- 1 January 2004
- journal article
- mechanisms of-disease
- Published by Elsevier in The Lancet
- Vol. 363 (9404) , 203-209
- https://doi.org/10.1016/s0140-6736(03)15326-3
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Minimum information about a microarray experiment (MIAME)—toward standards for microarray dataNature Genetics, 2001
- High-fidelity mRNA amplification for gene profilingNature Biotechnology, 2000
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- PRISM IIICritical Care Medicine, 1996
- Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum.The Journal of Experimental Medicine, 1996
- Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium.Journal of Clinical Investigation, 1993
- Hemodynamic patterns of meningococcal shock in childrenCritical Care Medicine, 1988
- A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance.Journal of Clinical Investigation, 1985
- Early released lipid‐soluble cardiodepressant factor and elevated oestrogenic substances in human septic shockEuropean Journal of Clinical Investigation, 1984
- Cardiac Actions of a Myocardial Depressant Factor Isolated from Shock PlasmaExperimental Biology and Medicine, 1971